Published in J Antimicrob Chemother on June 01, 1987
Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev (1999) 10.44
Sensitive biological detection method for tetracyclines using a tetA-lacZ fusion system. Antimicrob Agents Chemother (1990) 0.96
Hierarchical clustering schemes. Psychometrika (1967) 8.37
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother (2001) 5.83
Ecological basis of extinction risk in birds: habitat loss versus human persecution and introduced predators. Proc Natl Acad Sci U S A (2000) 5.21
Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol (1996) 4.50
Translocation of a discrete piece of deoxyribonucleic acid carrying an amp gene between replicons in Eschericha coli. J Bacteriol (1976) 4.37
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med (1997) 4.11
Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia. Biochim Biophys Acta (1994) 3.52
Characterization of a translocation unit encoding resistance to mercuric ions that occurs on a nonconjugative plasmid in Pseudomonas aeruginosa. J Bacteriol (1977) 2.80
Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol (1995) 2.80
In vitro formation of a complex between cytoskeletal proteins of the human erythrocyte. Nature (1979) 2.70
Isolation of a temperature-sensitive derivative of RP1. Plasmid (1980) 2.70
Regional preference of insertion of Tn501 and Tn802 into RP1 and its derivatives. Mol Gen Genet (1978) 2.59
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
An ultra-rapid method for the study of antibiotic resistance plasmids. J Antimicrob Chemother (1986) 2.22
Inhibition of TnA translocation by TnA. J Bacteriol (1977) 2.20
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Transposition of TnA does not generate deletions. Mol Gen Genet (1977) 2.17
Hippocampal volume in normal aging and traumatic brain injury. AJNR Am J Neuroradiol (1997) 2.17
Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study. Neurology (1999) 2.15
The colonization of the human gut by antibiotic resistant Escherichia coli from chickens. J Appl Bacteriol (1977) 2.08
Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1997) 2.07
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2001) 1.87
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Structure of straight flagella from a mutant Salmonella. J Mol Biol (1972) 1.83
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Regulation of isocitrate dehydrogenase activity in Escherichia coli on adaptation to acetate. J Gen Microbiol (1971) 1.72
Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study. Brain (1999) 1.71
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Pathological and microbiological findings from incidents of unusual mortality of the common frog (Rana temporaria). Philos Trans R Soc Lond B Biol Sci (1996) 1.59
Like father, like son: young children's understanding of how and why offspring resemble their parents. Child Dev (1996) 1.58
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
A restriction enzyme map of R-plasmid RP1. Plasmid (1977) 1.54
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Messenger ribonucleic acid synthesis and degradation in Escherichia coli during inhibition of translation. J Bacteriol (1973) 1.48
PACs: classifying ambulatory care patients and services for clinical and financial management. J Ambul Care Manage (1988) 1.48
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology (1997) 1.47
Evaluation of covert video surveillance in the diagnosis of munchausen syndrome by proxy: lessons from 41 cases. Pediatrics (2000) 1.46
Effect of mutations in deoxyribonucleic acid repair pathways on the sensitivity of Escherichia coli K-12 strains to nitrofurantoin. J Bacteriol (1976) 1.44
Optical diffraction studies of myofibrillar structure. Philos Trans R Soc Lond B Biol Sci (1971) 1.43
Reversible inactivation of the isocitrate dehydrogenase of Escherichia coli ML308 during growth on acetate. J Gen Microbiol (1975) 1.42
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Escherichia coli CreBC is a global regulator of gene expression that responds to growth in minimal media. J Biol Chem (2001) 1.38
A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity. J Antimicrob Chemother (1995) 1.38
Sequence analysis of two chromosomally mediated inducible beta-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase. J Antimicrob Chemother (1995) 1.37
Traumatic brain injury and grey matter concentration: a preliminary voxel based morphometry study. J Neurol Neurosurg Psychiatry (2005) 1.34
Characterisation of Tn501, a transposon determining resistance to mercuric ions. Mol Gen Genet (1978) 1.33
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc (1999) 1.32
Intracistronic polarity during dissociation of translation from transcription in Escherichia coli. J Mol Biol (1973) 1.32
Nonspecific white matter degeneration following traumatic brain injury. J Int Neuropsychol Soc (1995) 1.32
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Nucleotide and amino acid sequences of the metallo-beta-lactamase, ImiS, from Aeromonas veronii bv. sobria. Antimicrob Agents Chemother (1998) 1.29
Cardio-respiratory fitness of young and older active and sedentary men. Br J Sports Med (1988) 1.28
Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother (1999) 1.28
Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother (2000) 1.28
MR-based brain and cerebrospinal fluid measurement after traumatic brain injury: correlation with neuropsychological outcome. AJNR Am J Neuroradiol (1997) 1.28
Structure of the cross-striated adductor muscle of the scallop. J Mol Biol (1976) 1.27
A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother (2000) 1.26
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Cloning and characterization of an AAC(6') gene from Serratia marcescens. J Antimicrob Chemother (1988) 1.22
Distribution and expression of beta-lactamase genes among Aeromonas spp. J Antimicrob Chemother (1997) 1.22
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
Structure of the myosin-containing filament assembly (A-segment) separated from frog skeletal muscle. J Mol Biol (1971) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
A molecular analysis of transductional marker rescue involving P-group plasmids in Pseudomonas aeruginosa. Mol Gen Genet (1976) 1.18
Duplex microtubule is a new form of tubulin assembly induced by polycations. Nature (1975) 1.18
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
The occurrence and seasonal changes in the isolation of Listeria spp. in shop bought food stuffs, human faeces, sewage and soil from urban sources. Int J Food Microbiol (1994) 1.17
Citrobacter diversus ULA27 produces two forms of a chromosomal beta-lactamase. J Antimicrob Chemother (1987) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
Spread of a single plasmid clone to an untreated individual from a person receiving prolonged tetracycline therapy. Antimicrob Agents Chemother (1977) 1.14
Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother (2005) 1.14
Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13
The effects of fusidic acid on growth, ribosome synthesis and RNA metabolism in Escherichia coli. J Mol Biol (1974) 1.13
Emerging epidemic diseases of frogs in Britain are dependent on the source of ranavirus agent and the route of exposure. Epidemiol Infect (2006) 1.13
Heterogeneity at the beta-lactamase structural gene ampC amongst Citrobacter spp. assessed by polymerase chain reaction analysis: potential for typing at a molecular level. J Med Microbiol (1994) 1.12